Caracterização dos surtos causados pelo grupo Mycobacterium abscessus
PDF

Palavras-chave

micobactéria de crescimento rápido
Mycobacterium abscessus
surtos

Como Citar

1.
Carvalho NFG de, Ferrazoli L, Riveron MBA, Chimara E. Caracterização dos surtos causados pelo grupo Mycobacterium abscessus. Rev Inst Adolfo Lutz [Internet]. 1º de fevereiro de 2012 [citado 28º de março de 2024];71(2):228-36. Disponível em: https://periodicos.saude.sp.gov.br/RIAL/article/view/32419

Resumo

O gênero Mycobacterium contempla espécies do complexo M. tuberculosis e as denominadas micobactérias não tuberculosas (MNT). As micobactérias, quando em contato com o homem e alguns animais, podem causar doenças por meio de quebra da barreira do hospedeiro. Em virtude de sua natureza ambiental e muitas vezes oportunista, as micobactérias de crescimento rápido podem causar infecções nosocomiais, e com maior frequência pela espécie Mycobacterium abscessus. O M. abscessus causa diversos tipos de infecções teciduais e é altamente resistente à maioria dos quimioterápicos. Foi realizada uma revisão da literatura sobre os surtos de ocorrência nacional e internacional, com o objetivo de averiguar as principais causas que facilitaram a sua proliferação. Em 28 publicações, foram descritas as características das MNT e 15 trabalhos foram referentes ao relato de surtos, dos quais três nacionais associados aos procedimentos clínicos invasivos e 12 internacionais, correlacionados aos procedimentos médicos não invasivos. Todos os artigos relataram a frequente ocorrência de práticas inadequadas de limpeza, de procedimentos e de desinfecção. Estes fatos mostram a necessidade de sistema de qualidade mais eficiente e de estudos adicionais sobre a natureza do agente patogênico para tomada de medidas profiláticas mais efetivas.
https://doi.org/10.53393/rial.2012.v71.32419
PDF

Referências

1. Primm TP, Lucero CA, Falkinham JO. Health impacts of environmental mycobacteria. Clin Microbiol Reviews. 2004;17:98-106.

2. Groote MAD, Huitt G. Infections Due to Rapidly Growing Mycobacteria. Clin Infect Dis. 2006;42:1756-63.

3. Falkinham JO. Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment. J Appl Microbiol. 2009;107(2):356-67.

4. Medjahed H, Gaillard J, Reyrat J. Mycobacterium abscessus: a new player in the mycobacterial field. Trends Microbiol. 2010;18(3):117-23.

5. Runyon EH. Anonymous mycobacteria in pulmonary disease. Med Clin North America. 1959;43:273-90.

6. Tortoli E. Clinical manifestation of nontuberculous mycobacteria infections. Clin Microbiol Infect Dis. 2009;15:906-10.

7. Jarzembowski JA, Young MB. Nontuberculous Mycobacterial Infections. Arch Pathol Lab Med. 2008;132:1333-41.

8. Wongkitisophon P, Rattanakaemakon P, Tanrattanakorn S, Vachiramon V. Cutaneous Mycobacterium abscessus infection associated with mesotherapy injection. Case Reports in Dermatology. 2011;3:37-41.

9. Gayathri R, Lily TK, Deepa P, Mangal S, Madhavan HN. Antibiotic susceptibility pattern of rapidly growing mycobacteria. J Post Med. 2010;56(2):76-8.

10. Catherinot E, Clarissou J, Etienne G, Ripoll JF, Daffé M, Perronne C, et al. Hypervirulence of a rough variant of the Mycobacterium abscessus type strain. Infect Immun. 2007;75(2):1055-8.

11. Telenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol. 1993;31:175-8.

12. Adékambi T, Reynaud – Gaubert M, Greub G, Gevaudan MJ, La Scola B, Raoult D, et al. Amoebal coculture of “ Mycobacterium massiliense” sp. Nov. from the sputum of a patient with hemoptoic pneumonia. J Clin Microbiol. 2004;42(12):5493-501.

13. Ingen J van, Zwaan R, Dekhuijzen RPN, Boeree MJ, Soolingen D van. Clinical relevance of Mycobacterium chelonae – abscessusgroup isolation in 95 patients. J Infect. 2009;59:324-31.

14. Leão SC, Tortoli E, Viana-Niero C, Ueki SYM, Lima KVB, Lopes ML, et al. Characterization of Mycobacteria from a Major Brazilian Outbreak Suggest that Revision of the Taxonomic Status of Members of the Mycobacterium chelonae – M. abscessusGroup is needed. J Clin Microbiol. 2009;47(9):2691-8.

15. Leão SC, Viana-Niero C, Matsumoto CK, Lima KVB, Lopes ML, Palaci M, et al. Epidemic of surgical – site infections by a single clone of rapidly growing mycobacteria in Brazil. Future Microbiol. 2010;5(6):971-80.

16. Huang YC, Liu MF, Shen GH, Lin CF, Kao CC, Liu PY, et al. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.JMicrobiol Immunol Infect. 2010;43(5):401-6.

17. Adekambi T, Berger P, Raoult D, Drancourt M. rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov. Int J Sys Evol Microbiol. 2006;56:133-43.

18. Duarte RS, Lourenço MC, Fonseca LS, Leão SC, Amorim EL, Rocha IL, et al. Epidemic of Postsurgical Infections caused by Mycobacterium massiliense. J Clin Microbiol. 2009;47(7):2149-55.

19. Padoveze MC, Fortaleza CM, Freire MP, Assis DB, Madalosso G, Pellini AC, et al. Outbreak of surgical infection caused by non-tuberculous mycobacteria in breast implants in Brazil. J Hosp Infect. 2007;67:161-7.

20. Lopes ML, Lima KVB, Leão SC, Souza MS, Santili LQ, Loureiro ECB. Micobacterioses associadas a procedimentos médicos invasivos em Belém. Rev Par Med. 2005;19:87-9.

21. Villanueva A, Calderon RV, Vargas BA, Ruiz F, Aguero S, Zhang Y, et al. Report on an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction. Clin Infect Dis. 1997;24(6):1147-53.

22. Galil K, Miller LA, Yakrus MA, Wallace RJ Jr, Mosley DG, England B, et al. Abscesses due to Mycobacterium abscessus linked to injection of unapproved alternative medication. Emerg Infect Dis. 1999;5(5):681-7.

23. Zhibang Y, Bixia Z, Qishan L, Lihao C, Xiangquan L, Huaping L. Large-scale outbreak of infection with Mycobacterium chelonaesubsp. abscessus after penicillin injection. J Clin Microbiol. 2002;40 (7):2626-8.

24. Tiwari TS, Ray B, Jost KCJr, Rathod MK, Zhang Y, Brown-Elliott BA, et al. Forty years of disinfectant failure: outbreak of postinjection Mycobacterium abscessus infection caused by contamination of benzalkonium chloride. Clin Infect Dis. 2003;36(8):954-62.

25. Toy BR, Frank PJ. Outbreak of Mycobacterium abscessus infection after soft tissue augmentation. Dermatol Surg. 2003;29(9):971-3.

26. Yuan J, Liu Y, Yang Z, Cai Y, Deng Z, Qin P, et al. Mycobacterium abscessus post-injection abscesses from extrinsic contamination of multiple-dose bottles of normal saline in a rural clinic. Int J Infect Dis. 2009;13(5):537-42.

27. Song JY, Sohn JW, Jeong HW, Cheong HJ, Kim WJ, Kim MJ. An outbreak of post-acupuncture cutaneous infection due to Mycobacterium abscessus. BMC Infect Dis. 2006;6(6). Disponível em: [http://www.biomedcentral.com/1471-2334/6/6].

28. Koh SJ, Song T, Kang YA, Choi JW, Chang KJ, Chu CS, et al. An outbreak of skin and soft tissue infection caused by Mycobacterium abscessus following acupuncture. Clin Microbiol Infect. 2010;16(7):895-901.

29. Wenger JD, Spika JS, Smithwick RW, Pryor V, Dodson DW, Carden GA, et al. Outbreak of Mycobacterium chelonae infection associated with use of jet injectors. JAMA. 1990;264(3):373-6.

30. Nakanaga K, Hoshino Y, Era Y, Matsumoto K, Kanazawa Y, Tomita A, et al. Multiple cases of cutaneous Mycobacterium massiliense infection in a “ hot spa” in Japan. J Clin Microbiol. 2011;49(2):613-7.

31. Maloney S, Welbel S, Daves B, Adams K, Becker S, Bland L, et al. Mycobacterium abscessus pseudoinfection traced to an automated endoscope washer: utility of epidemiologic and laboratory investigation. J Infect Dis. 1994;169:1166-9.

32. Furuya EY, Paez A, Srinivasan A, Cooksey R, Augenbraun M, Baron M, et al. Outbreak of Mycobacterium abscessus wound infections among “lipotourists” from the United States who underwent abdominoplasty in the Dominican Republic.Clin Infect Dis. 2008;46(8):1181-8.

33. Viana-Niero C, Lima KV, Lopes ML, Rabello MC, Marsola LR, Brilhante VC, et al. Molecular characterization of Mycobacterium massiliense and Mycobacterium bolletii in isolates collected from outbreaks of infections after laparoscopic surgeries and cosmetic procedures. J Clin Microbiol. 2008;46(3):850-5.

34. Cardoso AM, Martins SE, Viana-Niero C, Bonfim BF, Pereira NZC, Leão SC, et al. Emergence of nosocomial Mycobacterium massiliense infection in Goiás, Brazil. Microbes and Infection. 2008;10(14-15):1552-7.

35. Moore M, Frerichs JB. An unusual acid-fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region; report of a case with a study of the organism, Mycobacterium abscessus, nov. sp. J Invest Dermatol. 1953;20:133-69.

36. BRASIL. Resolução ANVISA RDC nº 8, de 2009. Dispõe sobre as medidas para redução da ocorrência de infecções por Micobactérias de Crescimento Rápido - MCR em serviços de saúde. Diário Oficial [da] União, Poder Executivo, de 2 de março de 2009.

Creative Commons License
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.

Copyright (c) 2012 Natalia Fernandes Garcia de Carvalho, Lucilaine Ferrazoli, Maria Beatriz Acosta Riveron, Erica Chimara

Downloads

Não há dados estatísticos.